Moore Capital Management, LP Jazz Pharmaceuticals PLC Transaction History

Moore Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $2.08 Million - $2.38 Million	20,000 New	20,000 $2.13 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $719,800 - $857,329	-5,900 Reduced 49.17%	6,100 $789,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $1.1 Million - $1.32 Million	9,000 Added 300.0%	12,000 $1.49 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $401,939 - $481,410	3,000 New	3,000 $438,000
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $16.3 Million - $19.4 Million	-114,771 Reduced 71.46%	45,829 $7.15 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $20.8 Million - $25.8 Million	160,600 New	160,600 $25 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $25.4 Million - $29.4 Million	-169,449 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $12.2 Million - $14.4 Million	86,995 Added 105.51%	169,449 $28 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $8.7 Million - $11.9 Million	82,454 New	82,454 $11.8 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.